Alterations in ECM components and cell matrix interactions can serve as biomarkers for cancer diagnosis and prognosis. For example, elevated levels of certain MMPs or abnormal integrin expression patterns can indicate tumor presence and aggressiveness, aiding in early detection and treatment planning.
